A Proof of Concept Study of the Effects of LY2828360 in the Treatment of Patients With Osteoarthritic Knee Pain.

Trial Profile

A Proof of Concept Study of the Effects of LY2828360 in the Treatment of Patients With Osteoarthritic Knee Pain.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Apr 2013

At a glance

  • Drugs LY 2828360 (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Adverse reactions; Biomarker; Pharmacogenomic; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 20 Apr 2013 New source identified and integrated (European Clinical Trials Database record: EudraCT2010-024320-23).
    • 09 Mar 2013 Primary endpoint 'Pain-score' has not been met.
    • 09 Mar 2013 Primary endpoint 'Pain-intensity-difference' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top